// App-Quantinova.ai

Mo1262 : Pharmacologic Thromboprophylaxis Reduces Post-Hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Disease

Researchers

Presenter

  • Andrew Cagan

Principal Investigators

  • Vivian S. Gainer

  • Shawn N. Murphy

  • Isaac Kohane

  • Katherine P. Liao

  • Su-Chun Cheng

  • Tianxi Cai

  • Stanley Shaw

  • Elizabeth Scoville

  • Gauree G. Konijeti

  • Peter Szolovits

  • Elizabeth W. Karlson

  • Susanne Churchill

Medical Centers

  • Partners Healthcare, Boston, MA

  • Massachusetts Institute of Technology, Cambridge, MA

  • Harvard School of Public Health, Boston, MA

  • Boston Children's Hospital, Boston, MA

  • Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA

  • Brigham and Women's Hospital, Brookline, MA

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Deep vein thrombosis

  • Venous thrombosis

  • Ulcerative colitis

  • Pulmonary embolism

  • Crohn's disease

Biomarkers

  • Creatinine

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved